LAG-3

2 stories · following the connections

Business

TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDA

By Nasdaq OMXMay 1, 2017, 12:32 PM UTC

Business

TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDA

By Nasdaq OMXMay 1, 2017, 12:32 PM UTC